WO2025240967 - A METHOD OF DETERMINING NEUTRALIZING ANTIBODIES USING MODIFIED HEMAGGLUTINATION ASSAYS
National phase entry is expected:
Publication Number
WO/2025/240967
Publication Date
20.11.2025
International Application No.
PCT/US2025/030031
International Filing Date
19.05.2025
Title **
[English]
A METHOD OF DETERMINING NEUTRALIZING ANTIBODIES USING MODIFIED HEMAGGLUTINATION ASSAYS
[French]
PROCÉDÉ DE DÉTERMINATION D'ANTICORPS NEUTRALISANTS À L'AIDE DE DOSAGES D'HÉMAGGLUTINATION MODIFIÉS
Applicants **
VST LLC dba MEDGENE
GLOVER, Sherry, R.
YOUNG, Alan, John
Inventors
GLOVER, Sherry, R.
YOUNG, Alan, John
Priority Data
63/648,832
17.05.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
USPTO
* |
| * | |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2288 | |
| EPO | Filing, Examination, Granting | 14207 | |
| Japan | Filing, Examination, Granting | 2327 | |
| South Korea | Filing, Examination, Granting | 2432 | |
| USA | Filing, Examination, Granting | 4310 |
Total:
25,564
Contact Us
Abstract[English]
The present invention describes hemagglutination inhibition (HAI) assay methods to determine candidate subunit protein vaccines in the absence of using source viruses.[French]
La présente invention concerne des procédés de dosage d'inhibition d'hémagglutination (HAI) pour déterminer des vaccins protéiques à sous-unités candidates en l'absence d'utilisation de virus sources.